APA (7th ed.) Citation

YK, L., HH, H., N, K., UH, P., H, Y., EY, M., . . . SJ, U. (2024). Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cells. BMB reports, 57(6), 299.

Chicago Style (17th ed.) Citation

YK, Lee, Heo HH, Kim N, Park UH, Youn H, Moon EY, Kim EJ, and Um SJ. "Tumor Antigen PRAME Is a Potential Therapeutic Target of P53 Activation in Melanoma Cells." BMB Reports 57, no. 6 (2024): 299.

MLA (9th ed.) Citation

YK, Lee, et al. "Tumor Antigen PRAME Is a Potential Therapeutic Target of P53 Activation in Melanoma Cells." BMB Reports, vol. 57, no. 6, 2024, p. 299.